A detailed history of Pfm Health Sciences, LP transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 2,011,040 shares of PMVP stock, worth $3.24 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,011,040
Previous 1,275,462 57.67%
Holding current value
$3.24 Million
Previous $2.07 Million 45.01%
% of portfolio
0.18%
Previous 0.11%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.44 - $1.69 $1.06 Million - $1.24 Million
735,578 Added 57.67%
2,011,040 $3 Million
Q1 2024

May 14, 2024

SELL
$1.51 - $3.12 $298,302 - $616,359
-197,551 Reduced 13.41%
1,275,462 $2.17 Million
Q4 2023

Feb 14, 2024

BUY
$1.23 - $6.6 $218,828 - $1.17 Million
177,909 Added 13.74%
1,473,013 $4.57 Million
Q3 2023

Nov 14, 2023

BUY
$6.01 - $8.93 $6.41 Million - $9.53 Million
1,066,694 Added 467.01%
1,295,104 $7.95 Million
Q2 2023

Aug 14, 2023

SELL
$3.94 - $6.27 $747,090 - $1.19 Million
-189,617 Reduced 45.36%
228,410 $1.43 Million
Q1 2023

May 15, 2023

BUY
$4.77 - $9.16 $402,163 - $772,288
84,311 Added 25.26%
418,027 $1.99 Million
Q4 2022

Feb 14, 2023

SELL
$8.17 - $12.95 $4.26 Million - $6.75 Million
-521,448 Reduced 60.98%
333,716 $2.9 Million
Q3 2022

Nov 14, 2022

SELL
$11.4 - $17.18 $4.09 Million - $6.17 Million
-359,000 Reduced 29.57%
855,164 $10.2 Million
Q2 2022

Aug 15, 2022

BUY
$9.23 - $22.43 $7.09 Million - $17.2 Million
767,864 Added 172.05%
1,214,164 $17.3 Million
Q1 2022

May 16, 2022

BUY
$14.86 - $23.55 $2.35 Million - $3.72 Million
157,966 Added 54.79%
446,300 $9.29 Million
Q2 2021

Aug 16, 2021

BUY
$28.01 - $36.01 $8.08 Million - $10.4 Million
288,334 New
288,334 $9.85 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.